Results 161 to 170 of about 15,820 (232)
The safety of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension: Protocol for a systemic review and network meta-analysis. [PDF]
Gu ZC +6 more
europepmc +1 more source
The therapeutic role of exercise training during menopause for reducing vascular disease
Abstract Menopause marks a major milestone in female reproductive ageing. It is characterized by the cessation of ovarian function and a concomitant decline in hormones such as oestradiol. Subsequently, females undergoing menopausal transition experience a progressive increase in cardiovascular and cerebrovascular disease risk.
Conan L. H. Shing +4 more
wiley +1 more source
Abstract figure legend Endothelial specific molecule‐1 (ESM‐1) and guanylate binding protein‐1 (GBP‐1) are proteins that are produced by activated/dysfunctional endothelial cells and are increased and decreased, respectively, during preeclampsia. It remains to be established whether ESM‐1 and GBP‐1 could potentially be included as biomarkers for the ...
Ines Pronk +3 more
wiley +1 more source
Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach. [PDF]
Fox BM, Kasztan M.
europepmc +1 more source
Abstract figure legend Excessive hypercholesterolaemia during pregnancy impairs maternal endothelial function, which, in turn, drives the development of pre‐eclampsia and may also contribute to the increased risk of later‐life cardiovascular disease in women.
Amanda A. de Oliveira +3 more
wiley +1 more source
Abstract Arginine vasopressin is primarily recognized as an osmoregulatory hormone; however, its contribution to vascular tone and blood pressure regulation under basal and hypertensive conditions remains debated. This study examined the effects of vasopressin deficiency induced by neurointermediate pituitary lobectomy in Wistar and spontaneously ...
Gloria Marcela Villanueva‐Rodríguez +6 more
wiley +1 more source
Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants. [PDF]
More K +3 more
europepmc +1 more source
Targeting Peptidergic Systems for Melanoma Treatment. [PDF]
Sánchez ML, Mehboob R, Coveñas R.
europepmc +1 more source

